Review
Published on 15 Nov 2022
Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.912505
- 8,088 views
- 34 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,964 articles
articles
Case Report
Published on 15 Nov 2022
Case report: Rechallenge with EGFR–TKIs after immunotherapy in EGFR–mutated non–small cell lung cancer with leptomeningeal metastasis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.957661
- 4,685 views
- 5 citations
Original Research
Published on 15 Nov 2022
Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.989349
- 3,542 views
- 9 citations
Case Report
Published on 14 Nov 2022
RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1019932
- 2,322 views
- 1 citation
Original Research
Published on 14 Nov 2022
Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1042766
- 3,458 views
- 8 citations
Original Research
Published on 14 Nov 2022
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.968064
- 4,366 views
- 8 citations
Original Research
Published on 11 Nov 2022
Stage IV non-small cell lung cancer among young individuals: Incidence, presentations, and survival outcomes of conventional therapies
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.894780
- 4,636 views
- 3 citations
Original Research
Published on 11 Nov 2022
Wedge resection plus adequate lymph nodes resection is comparable to lobectomy for small-sized non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1022904
- 3,004 views
- 7 citations
Editorial
Published on 11 Nov 2022
Editorial: Impact of immunotherapy in lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1083524
- 4,132 views
- 10 citations
Case Report
Published on 10 Nov 2022
Primary pulmonary T-cell lymphoma after operation for small intestinal stromal tumor: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.926121
- 2,246 views
Original Research
Published on 10 Nov 2022
Survival analysis and development of a prognostic nomogram for patients with malignant mesothelioma in different anatomic sites
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.950371
- 2,993 views
- 3 citations
Systematic Review
Published on 10 Nov 2022
Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.968517
- 4,004 views
- 17 citations
Original Research
Published on 09 Nov 2022
PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.909721
- 4,543 views
- 7 citations
Mini Review
Published on 09 Nov 2022
Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.978608
- 2,966 views
- 6 citations
Original Research
Published on 09 Nov 2022
Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1059253
- 3,146 views
- 7 citations
Original Research
Published on 08 Nov 2022
Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.999606
- 2,800 views
- 5 citations
Original Research
Published on 08 Nov 2022
Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.972972
- 3,924 views
- 5 citations
Case Report
Published on 07 Nov 2022
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1038774
- 4,465 views
- 8 citations
Case Report
Published on 07 Nov 2022
Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.985446
- 2,466 views
- 6 citations
Systematic Review
Published on 03 Nov 2022
Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.920709
- 6,447 views
- 9 citations
Case Report
Published on 02 Nov 2022
Lung adenocarcinoma concurrent with congenital pulmonary aplasia of the right upper lobe: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.959502
- 1,916 views
Original Research
Published on 02 Nov 2022
Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.988332
- 3,097 views
- 6 citations
Case Report
Published on 01 Nov 2022
Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1020875
- 5,165 views
- 30 citations
Original Research
Published on 01 Nov 2022
Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.986367
- 3,817 views
- 11 citations